(SYNRIBO is registered trademarks TEVA PHARMACEUTICALS USA, INC.)
What is SYNRIBO:
SYNRIBO is a medicine that contains the active substance Omacetaxine Mepesuccinate and is available as Single-Use Vial.
Generic Name: Omacetaxine Mepesuccinate
Strength: 3.5 mg of omacetaxine mepesuccinate as a lyophilized powder.
Company: TEVA PHARMACEUTICALS USA, INC.
Packing: Single use Vial
Synribo – Omacetaxine Mepesuccinate 3.5 mg is supplied for Tenders, Emergency imports, Orphan drug, Reference listed drugs, Comparator Drug, Name patient medicine and Innovator samples etc.
In how many countries SYNRIBO is approved for marketing?
SYNRIBO is available/approved in USA and Europe. We can help you to access it in India.
What is SYNRIBO used for?
SYNRIBO is indicated for the treatment of adult patients with chronic or accelerated phase chronic myeloid leukemia (CML) with resistance and/or intolerance to two or more tyrosine kinase inhibitors (TKI).
How can I get SYNRIBO in India?
SYNRIBO is a prescription only drug and is not approved for marketing in India.
The Indian Pharma (IP) is a consulting pharmaceutical company which assists Patients in accessing medicines in India. The Indian Pharma facilitates such access only against valid prescriptions in conformity with all local laws and regulations.
Patients/ Clinicians / Researchers can contact IP at +91-120-4080562 or write to at – email@example.com
We facilitate by-
• Helping in documentation to import the medicine for personal use
• Finding Genuine and reliable source in USA, Europe and Japan
• Ensuring 100% transparency.
SYNRIBO can be shipped to Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Jaipur, Lucknow, Cochin and Pune and other cities in India.
The Indian Pharma can facilitate the supply of SYNRIBO (prescription medicines) to all locations in the world and in India after fulfilling the legal requirement.
The Indian Pharma does not manufacture, supply, re-sell or retail any drugs or medicines. All trademarks and other intellectual property in relation to drugs and medicines supplied to you by suppliers are owned by their respective manufacturers or licensees
Can I get SYNRIBO even if I am not based in India?
Almost all countries across the world have provisions for granting access to drugs prior to marketing approval for personal use for patients who have exhausted all other treatment options available in their country
The Indian Pharma (IP) can help patients in accessing/importing SYNRIBO, unapproved in their home country against a legitimate prescription and in conformity with all local laws and regulations of their home country.
Send your enquiry to find-
SYNRIBO in South East Asia – China (Beijing, Chongqing, Shanghai, Tianjin and Shenzhen), Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong.
SYNRIBO in United Arab Emirates – Iraq, Iran, Saudi Arabia, Jordan.
SYNRIBO in North America – Mexico.
SYNRIBO in South America – Argentina, Brazil, Chile, Colombia, Peru, Venezuela.
SYNRIBO in Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia.
SYNRIBO in Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia.
SYNRIBO in African Countries – Algeria, Mauritius, Uganda, Zimbabwe.
SYNRIBO in Australia and New Zealand.
How is SYNRIBO used?
SYNRIBO should be administered under the guidance of specialist doctor having experience in managing cancer treatments.
Recommended dose- 1.25 mg/m2 administered by subcutaneous injection twice daily for 14 consecutive days of a 28-day cycle.
If the patient develops certain serious side effects then doctor may interrupt or stop treatment, or reduce the dose. See the summary of product characteristics on company official website for more information
Are there any side-effects/ adverse reactions/precautions associated with treatment with SYNRIBO?
It is recommended to seek your doctor’s medical advice about side effects
How do I contact The Indian Pharma?
You can use different channel to contact The Indian Pharma (IP)
Tele & Mobile: You can reach us on +91 8826990915 or +91-120-4080562 on any working days.
Email: We can also address your enquiries if sent directly to firstname.lastname@example.org. We will respond within 24 hours after receiving your mail. Please mention detailed enquiry, your contact number with ISD code while sending your mail. We will respond within 1 working days after receiving your query form.
What information do you need to help patient in assisting documentation for SYNRIBO import for personal use?
We will require the following documents to help in documentation for Named-Patient import
- Doctor’s Prescription – We would require prescription from Registered Medical Practitioner Stating Product name, dosage, duration of treatment and diagnosis
- Patient’s Medical history – We would require all test reports and Medical reports of the patient for last 3 months.
- Patient’s Identity card – We will require scan copy of Patient’s identity card and proof of residence to initiate documentation process. You can use copy of Passport, Driving License, Employee ID card or any Photo ID document as your Identity card.